двухростковый лейкоз
In this aspect interest work Newman [37] devoted to local relapses after operations of similar type also deserves. At 372 patients with a cancer dairy железы T1, T2, for the period with 1986 till 1993, relapses have been marked at 23 sick (6,2 %) with the average period of occurrence 25 мес and in 96 % of cases have been submitted by palpated formations{educations} in a leather{skin} dairy железы. At 14 patients relapse has been subjected surgical иссечению in a combination with system therapy. The resection reconstructed железы has been executed at three patients. The full local control has been achieved at 74 % of patients. At nine (39 %) have developed the remote metastasises. At average term of supervision 26 мес 14 from 23 patients (61 %) are alive without attributes of illness, 7 (30 %) have died. Подробнее...
The sizes of tumoral formations{educations} after циторедуктивной operations essentially influence results of the subsequent therapy and the forecast of the patient. So, average life expectancy of patients with the sizes of residual tumoral units less than 0,5 sm make 40 months, and at the sizes of 18 and 6 months of 0,5-2 and more 2 sm accordingly [2]. For this reason optimum executed циторедуктивной operation considers at what the maximal sizes of the staying tumoral formations{educations} do not exceed 2 see. In some centers under optimum циторедукцией accept the sizes of the staying tumoral formations{educations} less than 1 see. For achievement similar циторедукции the surgeon sometimes should carry out plural resections of a gut, a liver, a spleen, a bladder, a diaphragm, to use ultrasonic аспиратор and laser коагулятор for removal{distance} fine диссеминатов. Clearly, that циторедуктивные operations are considered technically complex{difficult} and demand high qualification of the surgeon specializing in онкогинекологии. Despite of all this, frequency of performance optimum циторедукции in conducting{leading} clinics of the world makes 23-54 %, and only separate authors achieve it at 75-90 % of patients. Подробнее...
